Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

The launch of AlbuFree™ DX underscores Dyadic’s strategy to prioritize recombinant protein products that have clear commercial pathways and are supported by well-established end markets. Under the ...

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They're easy to precisely produce. They're safe, and potentially ...

With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.

Cytiva introduced a new technology called Protein Select that the company says is designed to streamline and accelerate recombinant protein purification. The self-cleaving traceless tag and ...

With complex biologics such as monoclonal antibodies (mAb), antibody-drug conjugates (ADCs) and cell and gene therapies (CGTs) attracting the attention of global big pharma companies, the scope of ...

PRESS RELEASE Strategic research collaboration to advance MTx’s recombinant polyclonal IgG technologyAgreement includes R&D funding for exploratory work, technology access and, assuming exercise of ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

The pre-Series A funding round was co-led by existing backer WaterBridge Ventures and Japanese VC firm Enrission India Capital Founded in 2019, Loopworm manufactures high-protein animal feeds from ...